Zoetis (NYSE: ZTS) EVP receives new RSU and stock option awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Zoetis Inc. Executive Vice President Jamie Brannan received new equity awards. On February 18, 2026, Brannan was granted 5,399 restricted stock units and 21,361 stock options, each at an exercise price of $0.00 per unit or option.
Each RSU represents a contingent right to receive one share of Zoetis common stock. One-third of the RSUs and one-third of the options will vest on each of the first, second and third anniversaries of the grant date, subject to continued service and certain earlier-vesting events. Following these grants, Brannan directly holds RSUs and multiple option positions reflecting prior annual awards under the company’s equity and incentive plans.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Brannan Jamie
Role
Executive Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit | 5,399 | $0.00 | -- |
| Grant/Award | Stock Option | 21,361 | $0.00 | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
| holding | Stock Option | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 5,399 shares (Direct);
Stock Option — 21,361 shares (Direct)
Footnotes (1)
- Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Not applicable. One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026. Each option expires on the tenth anniversary of the date of grant. One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025. One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024. One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023. Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. 2,764 options granted February 13, 2018 at an exercise price of $73.24 per option; 1,465 options granted February 12, 2019 at an exercise price of $87.51 per option; 732 options granted February 11, 2020 at an exercise price of $144.03 per option; 869 options granted February 10, 2021 at an exercise price of $160.62; and 1,111 options granted February 8, 2022 at an exercise price of $201.30 per option. Each option vested on the third anniversary of the date of grant.
FAQ
What equity awards did Zoetis (ZTS) grant to Executive Vice President Jamie Brannan?
Zoetis granted Jamie Brannan 5,399 restricted stock units and 21,361 stock options on February 18, 2026. These awards were issued under the Zoetis equity and incentive plans as part of his executive compensation package, aligning his interests with long-term shareholder value.
How do the new RSU awards for Zoetis (ZTS) EVP Jamie Brannan vest?
The 5,399 restricted stock units vest in three equal installments on the first, second and third anniversaries of the February 18, 2026 grant date. Vesting is conditioned on Brannan’s continued service and may accelerate upon specific events described in the award terms.
What are the key terms of Jamie Brannan’s new Zoetis (ZTS) stock option grant?
Brannan received 21,361 stock options that vest one-third on each of the first, second and third anniversaries of the February 18, 2026 grant date. Each option has a ten-year term from grant, consistent with the Zoetis equity and incentive plan documentation.
Do Jamie Brannan’s Zoetis (ZTS) RSUs convert into common stock?
Each restricted stock unit represents a contingent right to receive one share of Zoetis common stock. Shares are delivered as units vest and settle, meaning the underlying stock is issued over time as vesting conditions tied to continued service are satisfied.
What existing equity holdings for Zoetis (ZTS) EVP Jamie Brannan are shown in this Form 4?
The filing updates Brannan’s direct holdings in RSUs and stock options from earlier grants. It lists outstanding RSU balances and option positions from prior annual awards, reflecting their remaining totals after previous vesting while not indicating any sales or disposals.
Under which plan were Jamie Brannan’s new Zoetis (ZTS) awards granted?
The RSUs and stock options were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. This plan provides stock-based compensation to executives, linking a portion of their pay to the company’s performance and long-term share price.